All In MedTech

FDA Clearance Tracker · P960009-S415

Activa® Deep Brain Stimulation Therapy System, Percept™ PC BrainSense™

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 1, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 1, 2022

Approved

Time to decision

76 days

Received Nov 17, 2021. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P960009-S415
Device name
Activa® Deep Brain Stimulation Therapy System, Percept™ PC BrainSense™
Applicant location
Minneapolis, MN
Received
Nov 17, 2021
Decided
Feb 1, 2022
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P960009

Device type

Device class
Class III

Every decision under product code MHY

FDA's approval statement

As written in FDA's record.

Approval for extending the device lifetime of the Model B31060 Connector Plug from 11 to 15 years.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.